Menopause, HRT and oral contraceptive Flashcards

1
Q

Why can’t we measure GnRH

A

It’s not in the peripheral circulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is a common symptom of menopause

A

Sleep Disturbance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What may be some of the patient worries regarding HRT and menopause

A
Bones- damaging effects of menopause on the bone (loss of bone density)
Breast cancer (side effects of HRT)
‘Blood clots in the leg’
Stroke
‘Heart attack’- CVS effects of HRT
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Define menopause

A

Permanent cessation of menstruation
Loss of ovarian follicular activity
They stop making estradiol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the key features of menopause

A

Average age 51 (range 45-55)

Climacteric: period of transition period- periods become irregular until they eventually stop.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How do some women view menopause

A

This is a natural process of life.

The body at the beginning will get a bit mad.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe the eventual transition to menopause

A

Climacteric period

You go from having normal regular cycles and then it becomes a little irregular (oligomenorrhoea) and then it progresses to amenorrhoea.
Permanent cessation of menstruation - amenorrhoea for more than 12 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

State the symptoms of menopause

A
Hot flushes (head, neck, upper chest)
Urogenital atrophy & dyspareunia (pain having sexual intercourse)

Sleep disturbance
Depression
Decreased libido
Joint pain

Symptoms usually diminish/disappear with time.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What do the ovaries produce that has feedback on the HPG axis

A

Oestradiol and Inhibin B

Negative feedback at the level of the anterior pituitary and the hypothalamus.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe the hormonal changes in menopause

A

The ovaries no longer produce estradiol and inhibin B
Hence, less negative feedback on the anterior pituitary and the hypothalamus
High GnRH, high LH and high FSH.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe how oesteoporosis is a key complication of menopause

A

Oestrogen deficiency
Loss of bone matrix
10-fold increased risk of fracture
§ Loss of 1-3% of bone mass/year and have 10x increase risk of fracture.

Lose anabolic effects of oestrogen on bone (via osteoblasts).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe cardiovascular disease as a key complication of menopause

A

protected against CVD before the menopause

have the same risk as men by the age of 70

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the key aim of HRT

A

Control vasomotor symptoms (hot flushes) - which are very problematic for paitents- major disruption to their life.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Summarise the basis of HRT that should be given to post-menopausal women

A

Oestrogen (E):
endometrial proliferation
risk of endometrial carcinoma

Progestogens (P)- sheds endometrial lining- thus reducing the risk of endometrial cancer

HRT: E + P to prevent endometrial hyperplasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe the basis of HRT is the woman has had a hysterectomy

A

(If hysterectomy: E only)

No endometrium, thus no risk of endometrial cancer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe two common HRT formulations

A

can be cyclical, with oestrogen daily and progesterone every two weeks, or continuous combined

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Describe the different oestrogen preparations

A

Oral estradiol (1mg)
Oral conjugated equine oestrogen (0.625 mg)
Transdermal (patch) oestradiol (50 microgram/day)
Intravaginal

18
Q

Describe the absorption and metabolism of estradiol

A

Oestradiol is absorbed well but it is heavily metabolised in the liver (first pass) so the bioavailability is very low.

This means that in oral preparations, you must give a high dose of oestradio

19
Q

Describe some different preparations of estradiol

A

Estrone sulphate (‘conjugated’ oestrogen)

Ethinyl estradiol :a semi-synthetic oestrogen
The ethinyl group protects the molecule from first pass metabolism- core part or oral contraceptives.

20
Q

What can most oestrogens be administered as

A

Most oestrogens can also be administered via transdermal skin patches

21
Q

State some of the side effects of HRT

A
Breast cancer
Coronary heart disease
Deep Vein thrombosis
Stroke
Gallstones
22
Q

What is the key difference between the doses of oestrogen given in HRT and the doses in oral contraceptives

A

In HRT you are just giving a little bit of oestrogen to prevent the symptoms of menopause.

In contraception, you are trying to suppress the HPG axis so you give a more potent type of oestrogen.

23
Q

What is important to remember regarding the absolute risk of HRT complications

A

The absolute risk of complications for healthy symptomatic postmenopausal women in their 50s taking HRT for five years is very low.

24
Q

What are the take home messages form the WHI trials

A

Increased risk of CHD events!
19 additional events/yr per 10,000 women

Mean age: 63 years

Timing of exposure is important
No excess risk in younger menopausal women

Women < 10 years since menopause or 50-59 years: no excess risk

25
Describe and explain the results from the WHI trials
``` Additional cases per 1000 women (compared to oestrogen alone) taking combined (E+P) HRT for 5 years: ``` Breast cancer (invasive): 3 CHD: 2.5 DVT: 5 Stroke: 2.5 However both are protective against all cause mortality. When you are young: Oestrogen: beneficial effects on lipid profile & endothelial function Synthetic progestins: Negate these effects of estrogen ``` Over 60 Atherosclerosis Susceptible to prothrombotic & proinflammatory effects of oestrogen Hence the increased risk of CHD in this study. ```
26
Describe tiobolone
Synthetic prohormone Oestrogenic, progestogenic & weak androgenic actions Reduces fracture risk Increased risk of stroke (RR: 2.2) ? increased risk of Breast Ca
27
Which property of oestrogen receptors do SERMs exploit
They have different structures at different sites in the body- allowing SERMs to have agonistic effects at some sites, but antagonistic effects at other sites.
28
Describe raloxifene
Selective oestrogen receptor modulator Oestrogenic in bone: Reduces risk of vertebral fractures Anti-oestrogenic in breast & uterus reduces breast cancer risk Does not reduced vasomotor symptoms Increased risk of VTE & fatal stroke
29
What is tamoxifen
Anti-oestrogenic on breast tissue Used to treat oestrogen-dependent breast tumours & metastatic breast cancers But Oestrogenic effects on bone
30
Summarise premature ovarian insufficiency
Menopause occurring before the age of 40 1% of women Autoimmune Surgery Chemotherapy Radiation The last 3 are iatrogenic
31
When is raloxifene used
Used for treatment & prevention of postmenopausal osteoporosis
32
Describe the absorption and metabolism of progestogerones
Progesterone is poorly absorbed and rapidly metabolised in the liver. Progesterone can be given by intramuscular injection as a depot preparation. A variety of orally active synthetic progestogens are available e.g. norethisterone.
33
Describe combined oral contraceptives
Oestrogen (ethinyl oestradiol) + Progestogen (e.g. levonorgestrel or norethisterone) Suppress ovulation: E&P: negative feedback actions at hypothalamus/pituitary P thickens cervical mucus (makes it harder for sperm to fertilise the egg) Take for 21 days (or 12 weeks), stop for 7 days
34
Describe the key features of combined oral contraceptives
Combination of an oestrogen (ethinyl oestradiol) and a progestogen (e.g. levonorgestrel or norethisterone) provides synergistic pharmacology to suppress ovulation via multiple mechanisms: E upregulates P receptors. E counteracts the androgenic effects of synthetic P
35
What is the effect of oestrogen on weight
Increased weight (water retention and fat deposition)
36
When is the progesterone only contraceptive indicated
When oestrogens contra-indicated smoker, > 35 yrs old, migraine with aura e.g. CVS problems, history of thrombosis, prior to major surgery, during lactation (oestrogen should be low during lactation).
37
When should progesterone only contraceptives be given
Must be taken at the same time each day Short half-life Short duration of action
38
Describe some longer-lasting preparations of progesterones
Long acting preparations may be given by deep intramuscular injection (e.g. medroxyprogesterone acetate/Depot-Provera) or via an intra-uterine system (Mirena) Oral (‘POP’) preparations -progersterone only pill
39
Describe the morning after pill
Combined E & P or P only (levonorgestrel) 2 doses 12 hours apart, beginning as soon as possible within 72 hours of intercourse; single one-step double strength tablet also available. May cause nausea and vomiting
40
Describe copper IUD as emergency contraception
Copper IUD (intrauterine contraceptive device) exclude pregnancy first affects sperm viability and function- thus preventing fertilisation Effectiveness not reduced in overweight/obese women 5 (up to 7) days after unprotected intercourse
41
Describe urilipristal as emergency contraception
(up to 120 hours after intercourse) Anti-progestin activity delay ovulation by as much as 5 days Impairs implantation